Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,293 | 276 | 84.3% |
| Travel and Lodging | $982.84 | 3 | 13.2% |
| Education | $191.34 | 6 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teleflex LLC | $1,764 | 18 | $0 (2024) |
| Axonics, Inc. | $537.39 | 24 | $0 (2024) |
| Astellas Pharma US Inc | $531.41 | 30 | $0 (2024) |
| Rochester Medical Corporation | $505.50 | 22 | $0 (2022) |
| PROCEPT BioRobotics Corporation | $420.83 | 10 | $0 (2024) |
| COLOPLAST CORP | $343.67 | 19 | $0 (2024) |
| PFIZER INC. | $267.24 | 11 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $258.38 | 15 | $0 (2024) |
| Antares Pharma, Inc. | $253.53 | 12 | $0 (2024) |
| Myovant Sciences Inc. | $217.84 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,460 | 62 | PROCEPT BioRobotics Corporation ($280.17) |
| 2023 | $1,530 | 62 | Astellas Pharma US Inc ($228.32) |
| 2022 | $3,113 | 94 | Teleflex LLC ($1,521) |
| 2021 | $1,364 | 67 | Axonics, Inc. ($209.80) |
All Payment Transactions
285 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $16.84 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/15/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: UROLOGY | ||||||
| 11/05/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $35.97 | General |
| Category: Urology Gynecology | ||||||
| 10/31/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/22/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/10/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Urology | ||||||
| 10/03/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $4.44 | General |
| Category: UROLOGY | ||||||
| 09/27/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Urology | ||||||
| 09/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: UROLOGY | ||||||
| 09/24/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $20.39 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 09/17/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Oncology | ||||||
| 09/13/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $23.34 | General |
| Category: UROLOGY | ||||||
| 09/10/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug), PIPELINE | Food and Beverage | In-kind items and services | $31.59 | General |
| Category: Oncology | ||||||
| 09/09/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: UROLOGY | ||||||
| 08/26/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/15/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/12/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $25.30 | General |
| Category: UROLOGY | ||||||
| 08/09/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $38.27 | General |
| Category: AMS 700_URO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 834 | 5,256 | $200,929 | $55,606 |
| 2022 | 12 | 907 | 2,593 | $160,021 | $48,662 |
| 2021 | 7 | 419 | 587 | $66,208 | $23,159 |
| 2020 | 6 | 175 | 201 | $22,881 | $7,497 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 182 | 232 | $54,520 | $18,430 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 170 | 215 | $34,400 | $12,616 | 36.7% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 15 | 3,952 | $34,009 | $8,618 | 25.3% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 19 | 101 | $24,846 | $5,871 | 23.6% |
| 54235 | Injection procedure to cause erection | Office | 2023 | 20 | 38 | $10,374 | $2,311 | 22.3% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 34 | 44 | $8,140 | $2,306 | 28.3% |
| 95972 | Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | Office | 2023 | 14 | 41 | $9,389 | $1,555 | 16.6% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 13 | 35 | $14,105 | $1,436 | 10.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 246 | 452 | $4,520 | $994.40 | 22.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 83 | 106 | $4,346 | $837.98 | 19.3% |
| 51701 | Insertion of temporary bladder tube | Office | 2023 | 16 | 17 | $2,142 | $495.20 | 23.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 23 | $138.00 | $135.24 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 236 | 312 | $73,320 | $26,339 | 35.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 139 | $22,240 | $8,336 | 37.5% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2022 | 13 | 1,352 | $11,492 | $2,851 | 24.8% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2022 | 14 | 32 | $7,872 | $1,901 | 24.1% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2022 | 30 | 37 | $6,845 | $1,884 | 27.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 151 | 194 | $7,954 | $1,601 | 20.1% |
| 95972 | Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | Office | 2022 | 16 | 41 | $9,389 | $1,594 | 17.0% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2022 | 14 | 27 | $10,881 | $1,142 | 10.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 15 | 15 | $2,400 | $935.28 | 39.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 273 | 413 | $4,130 | $912.51 | 22.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 12 | $1,104 | $591.30 | 53.6% |
| 51701 | Insertion of temporary bladder tube | Office | 2022 | 19 | 19 | $2,394 | $574.80 | 24.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 121 | 154 | $36,190 | $13,524 | 37.4% |
About Susan Greiner, PA-C
Susan Greiner, PA-C is a Physician Assistant healthcare provider based in East China, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851466825.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Susan Greiner, PA-C has received a total of $7,467 in payments from pharmaceutical and medical device companies, with $1,460 received in 2024. These payments were reported across 285 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($6,293).
As a Medicare-enrolled provider, Greiner has provided services to 2,335 Medicare beneficiaries, totaling 8,637 services with total Medicare billing of $134,925. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location East China, MI
- Active Since 11/22/2006
- Last Updated 02/18/2019
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1851466825
Products in Payments
- UroLift System (Device) $1,581
- XTANDI (Drug) $403.05
- AQUABEAM SYSTEM (Device) $280.17
- ORGOVYX (Drug) $272.71
- Axonics (Device) $270.93
- BOTOX (Biological) $265.15
- ELIGARD (Drug) $237.17
- ERLEADA (Drug) $218.79
- UROLIFT (Device) $182.89
- Axonics r-SNM System (Device) $180.31
- SpeediCath (Device) $179.35
- KEYTRUDA (Biological) $168.69
- Xtandi (Drug) $167.02
- GEMTESA (Drug) $164.05
- XIAFLEX (Biological) $160.19
- XYOSTED (Drug) $147.48
- AQUABEAM ROBOTIC SYSTEM (Device) $140.66
- JELMYTO (Drug) $139.60
- NOCDURNA (Drug) $132.04
- Myrbetriq (Drug) $131.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.